* AstraZeneca's Tagrisso slashes death risk in certain post-surgery lung cancer patients Reuters
* Lung cancer pill cuts risk of death by half, says ‘thrilling’ study The Guardian
* Stopping treatment at two years does not seem to compromise overall survival in patients with advanced lung cancer News-Medical.Net
* Game-Changer: Tagrisso May Reduce Risk of Death by Half in Some Early-Stage Lung Cancer Patients, 'Compelling' New Data Shows SurvivorNet
* 'Extraordinary' survival data for lung cancer patients is seen as boost for AstraZeneca drug STAT
* View Full Coverage on Google News
http://dlvr.it/Sq8xtD
